Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer The American College of Surgeons Oncology Group Z1071 trial reported a 12.6% ...
Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer Five hundred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results